» Articles » PMID: 25599080

IFITM-Family Proteins: The Cell's First Line of Antiviral Defense

Overview
Journal Annu Rev Virol
Publisher Annual Reviews
Specialty Microbiology
Date 2015 Jan 20
PMID 25599080
Citations 286
Authors
Affiliations
Soon will be listed here.
Abstract

Animal cells use a wide variety of mechanisms to slow or prevent replication of viruses. These mechanisms are usually mediated by antiviral proteins whose expression and activities can be constitutive but are frequently amplified by interferon induction. Among these interferon-stimulated proteins, members of the IFITM (interferon-induced transmembrane) family are unique because they prevent infection before a virus can traverse the lipid bilayer of the cell. At least three human IFITM proteins-IFITM1, IFITM2, and IFITM3-have antiviral activities. These activities limit infection in cultured cells by many viruses, including dengue virus, Ebola virus, influenza A virus, severe acute respiratory syndrome coronavirus, and West Nile virus. Murine Ifitm3 controls influenza A virus infection in vivo, and polymorphisms in human correlate with the severity of both seasonal and highly pathogenic avian influenza virus. Here we review the discovery and characterization of the IFITM proteins, describe the spectrum of their antiviral activities, and discuss potential mechanisms underlying these effects.

Citing Articles

Impact of single nucleotide polymorphism of IL-27P28 rs153109 and IFITM3 rs12252 on susceptibility and severity of COVID-19 in Egyptian patients: a case control study.

Hamdy H, Elhamammy R, Abdelmageed M, Wahid A Virol J. 2025; 22(1):66.

PMID: 40057761 PMC: 11889743. DOI: 10.1186/s12985-025-02668-z.


Host RNA-Binding Proteins as Regulators of HIV-1 Replication.

Giraldo-Ocampo S, Valiente-Echeverria F, Soto-Rifo R Viruses. 2025; 17(1).

PMID: 39861832 PMC: 11768693. DOI: 10.3390/v17010043.


Immune pathogenic response landscape of acute posterior multifocal placoid pigment epitheliopathy revealed by scRNA sequencing.

Liu J, Guo Q, Liu G, Wang W, Jin X, Hao B Genes Immun. 2025; .

PMID: 39774261 DOI: 10.1038/s41435-024-00316-0.


Swine RNF5 positively regulates the antiviral activity of IFITM1 by mediating the degradation of ABHD16A.

Shi X, Shen L, Chen S, Liu M, Wang J, Wen X J Virol. 2024; 99(1):e0127724.

PMID: 39601593 PMC: 11784460. DOI: 10.1128/jvi.01277-24.


Single cell multi-omic analysis identifies key genes differentially expressed in innate lymphoid cells from COVID-19 patients.

Kaushik A, Chang I, Han X, He Z, Komlosi Z, Ji X Front Immunol. 2024; 15():1374828.

PMID: 39026668 PMC: 11255397. DOI: 10.3389/fimmu.2024.1374828.


References
1.
Huang I, Bosch B, Li F, Li W, Lee K, Ghiran S . SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells. J Biol Chem. 2005; 281(6):3198-203. PMC: 8010168. DOI: 10.1074/jbc.M508381200. View

2.
Xu Y, Yang G, Hu G . Binding of IFITM1 enhances the inhibiting effect of caveolin-1 on ERK activation. Acta Biochim Biophys Sin (Shanghai). 2009; 41(6):488-94. DOI: 10.1093/abbs/gmp034. View

3.
Chandran K, Sullivan N, Felbor U, Whelan S, Cunningham J . Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science. 2005; 308(5728):1643-5. PMC: 4797943. DOI: 10.1126/science.1110656. View

4.
Feeley E, Sims J, John S, Chin C, Pertel T, Chen L . IFITM3 inhibits influenza A virus infection by preventing cytosolic entry. PLoS Pathog. 2011; 7(10):e1002337. PMC: 3203188. DOI: 10.1371/journal.ppat.1002337. View

5.
Jia R, Xu F, Qian J, Yao Y, Miao C, Zheng Y . Identification of an endocytic signal essential for the antiviral action of IFITM3. Cell Microbiol. 2014; 16(7):1080-93. PMC: 4065222. DOI: 10.1111/cmi.12262. View